Tue, Dec 1, 2015
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Valeant Welcomes John Paulson’s $1bn stake in Allergan

Wednesday, July 02, 2014

Komfie Manalo, Opalesque Asia:

Valeant Pharmaceuticals Inc's chief executive Michael Pearson on Thursday welcomed news that hedge fund manager John Paulson through his firm, Paulson & Co., is building a $1bn stake in Allergan, Reuters said.

Deal-making drug-maker Valeant has partnered with activist hedge fund manager Bill Ackman of Pershing Square to acquire Allergan and shake up its board.

In an interview with Canada's BNN TV, Pearson said he was delighted with Paulson’s move to buy six million shares at Allergan. "We do believe we'll get the 25 percent and the majority we need to get this deal consummated," he was quoted as saying.

According to the report, Paulson’s position, together with Pershing Square’s stocks, are sufficient to provide the group with a 25% support of Allergan shares required to call the special meeting to replace majority of Allergan’s current sitting board.

On Wednesday, Paulson announced he has built a $1bn stake in Allergan and supports a takeover of the Botox maker by Valeant. Paulson's position is a boost to Valeant and its partner in the hostile bid, Ackman. Valean......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing

  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Other Voices: Hedge fund marketing and the selling cycle[more]

    By Bruce Frumerman. How long is the selling cycle now? That’s a question my financial communications and sales marketing consulting firm has been asked on a regular basis by hedge fund firm owners and sales people, ever since we opened the doors to our firm in 1987 pre-crash. Wa

  2. People - Solus Alternative Asset Management adds chief strategist from BTIG[more]

    From PIonline.com: Daniel Greenhaus joined hedge fund manager Solus Alternative Asset Management as managing director and chief strategist. He will work closely with Chris Bondy, Solus’ chief economist, managing director and executive vice president, said Chris Pucillo, CEO and chief investmen

  3. Commodities - Stung by oil, distressed-debt traders see worst losses since '08[more]

    From Bloomberg.com: It’s mid-November, but for investors who trade in the debt of distressed companies, the year’s already done -- and they lost. Hedge funds that specialize in the debt are grappling with their worst declines in seven years. Funds managed by Knighthead Capital Management, Candlewood

  4. Opalesque Roundtable: Seeding deal terms can be onerous for hedge funds[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: Executives from fund of funds firms, family offices, a placement agent, a private equity firm, and an accounting firm gathered in Connecticut last month for the

  5. Opalesque Roundtable: Family offices flock to co-investment[more]

    Bailey McCann, Opalesque New York: Co-investments have been a hot topic for pension funds in recent years, as they try to move away from high fees and improve transparency. But now, family offices are more readily getting into the mix and establishing in-house deal teams, according to the delega